Multimodal anesthesia for robotic kidney removal
Official title: Efficacy of Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy: Impact on Recovery and Early Hospital Discharge.
Run by Fundacio Puigvert · NCT07558226 · Data updated 2026-11-12
This trial tests whether a multimodal anesthesia plan helps patients recover faster after robotic nephrectomy for cancer compared with standard anesthesia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Fundacio Puigvert Academic / other |
| Locations | 1 site (Barcelona, BARCELONA) |
| Status | Recruiting |
| Started | May 2, 2026 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT07558226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older undergoing elective oncological robotic partial or radical nephrectomy who are suitable for short-stay surgery (ASA I–III).
✕Probably not a fit
Patients with chronic opioid use, uncontrolled chronic pain, NSAID or regional anesthesia contraindications, or advanced renal failure (GFR <30 mL/min) may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled study comparing multimodal anesthesia to conventional anesthesia in adults undergoing oncological robotic nephrectomy within a short-stay program. The study aims to see if the multimodal approach reduces hospital admission time and enables earlier discharge, without focusing on a specific drug. Enrolled patients will be randomized 1:1 and followed from preoperative assessment through 30 days post-surgery. The trial is being conducted at Fundacio Puigvert in Barcelona and is planned to run over about 18 months, enrolling about 80 participants.
Why it matters
Potential benefit: If successful, patients may experience shorter hospital stays and faster return to routine activities after robotic nephrectomy.
How similar studies have gone: Prior studies in multimodal anesthesia show potential for faster recovery in various surgical settings, but applicability to robotic nephrectomy with short-stay protocols is being explored here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients ≥18 years. * Indication for elective oncological robotic partial or radical nephrectomy. * ASA classification I-III. * Candidates for short-stay surgery according to institutional protocol. * Signed informed consent. Exclusion Criteria: * Chronic opioid use. Defined as continuous opioid use during the 3 months prior to surgery * Uncontrolled chronic pain. Defined as chronic pain not adequately controlled with usual treatment during the 3 months prior to surgery. * Contraindications to NSAIDs, regional anesthesia, or drugs of the multimodal protocol. * Advanced renal failure (GFR \<30 ml/min) at the preanesthetic visit.
Where it's running
-
Fundacio Puigvert
Barcelona, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Diana Vernetta, Md — Fundacio Puigvert Iuna
- Study coordinator: Diana Vernetta, Md
- Email: dvernetta@fundacio-puigvert.es
- Phone: 0034934169700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Recovery, quality of life, and physical function after partial or radical nephrectomy
This study tests recovery, quality of life, and physical function before and after nephrectomy to see how patients fare depending on the surgery type.
-
Does warming patients before surgery affect lactate levels after nephrectomy?
This observational study looks at whether warming patients before kidney removal surgery changes blood lactate and helps recovery.
-
R.E.C.K versus Exparel for pain control during robotic kidney removal
This will test whether intraoperative R.E.C.K or Exparel gives better pain control and reduces opioid use in adults having robotic partial or radical nephrectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.